Boston, MA
,
USA
·
North America
Polaris Partners is a Boston-based seed and Series A through Series B venture capital firm focused on healthcare and life sciences, investing in biopharmaceutical, medical technology, and digital health companies across their full development lifecycle. The firm has been investing in healthcare since its founding in 1996 and has developed a deep scientific team capable of evaluating drug discovery, device engineering, and digital health technology. Polaris invests with initial checks from $5 million to $25 million. Portfolio companies include Acusela, the retinal disease company; Aileron Therapeutics, the clinical-stage company developing stapled peptides; Avrobio, the gene therapy company developing treatments for rare diseases; and Bicycle Therapeutics, the UK clinical-stage company developing bicyclic peptide cancer treatments. Beyond its original investments, the portfolio includes dozens of additional clinical-stage healthcare and life science companies.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
